Our Work

Identifying the right therapeutic targets is a cornerstone of drug discovery, yet the process remains largely unstandardized.Increasingly, Artificial Intelligence (AI) and machine learning (ML) are being leveraged to accelerate and refine this step, with the aim of uncovering clinically meaningful targets.Identifying the right therapeutic targets is a cornerstone of drug discovery, yet the process remains largely unstandardized.Increasingly, Artificial Intelligence (AI) and machine learning (ML) are being leveraged to accelerate and refine this step, with the aim of uncovering clinically meaningful targets.

Target Identification for Drug Discovery

TargetDys has established an AI-driven, comprehensive framework for target identification that integrates multiple critical dimensions: disease relevance, target biology, mechanism of action, pathway mapping, toxicity risk, druggability, potential for combination therapy, as well as market dynamics and competitive landscape. By synthesizing these factors, the platform generates a curated portfolio of high-value targets, classified into two key categories:

Novel Targets: Previously unexplored, innovative targets with strong potential for breakthrough therapies.

Fast Follower Targets: Established and validated targets with limited competition, offering opportunities for differentiation and rapid development.

Suitable for

Emerging biotech firms and research institutions seeking to identify high‑quality targets for initiating drug development programs.

Established pharmaceutical companies aiming to broaden and strengthen their pipelines with strategically selected targets.

Drug Discovery Targets Network

• Antibodies

• ATPases

• Deubiquitinating Enzymes

• DNA Repair Enzymes

• Epigenetic Targets

• E3 Ligases

• Exonucleases

• GPCRs (G‑Protein Coupled Receptors)

• GTPases

• Helicases

• Immune Checkpoint Proteins

• Kinases

• Mitochondrial Chaperones

• Molecular Motor Proteins

• Nuclear Receptors

• Phosphatases

• Phosphodiesterases

• PROTAC / Glue Degrader Targets

• Proteases

• RNA Modifiers

• Scaffolding Proteins

Drug Discovery Targets